---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-110897"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2025-11-14T23:59:59+00:00"
generated_at: "2026-05-16T19:52:35.294234+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ENDRA regains Nasdaq equity compliance after $4.9M offering; adds crypto treasury

## Summary
- Closed Oct 2025 private placement raising ~$4.9M gross via 744,340 shares and warrants.
- Purchased 78,863.1 HYPE tokens on Oct 23, 2025 under new digital asset treasury strategy.
- Entered ATM sales agreement with Lucid Capital Markets for up to $1.75M in common stock.
- Nasdaq granted extension to Nov 24, 2025; company now believes it meets $2.5M equity minimum.

## SEC filing metadata
- accession: 0001213900-25-110897
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2025-11-14T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000121390025110897/0001213900-25-110897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000121390025110897/ea0265626-8k_endra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-110897
- JSON: https://secwatch.observer/filing/0001213900-25-110897.json
- Plain text: https://secwatch.observer/filing/0001213900-25-110897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.